Berberine and DHB Medication Interactions: What to Check With Your Doctor First

Berberine and DHB Medication Interactions: What to Check With Your Doctor First

If you take diabetes medication, blood pressure pills, a statin, a blood thinner, cyclosporine or tacrolimus, or a GLP-1 drug, talk with your doctor or pharmacist before starting any supplement with berberine or dihydroberberine (DHB). Berberine has documented effects on drug levels and blood sugar. Avoid it if you are pregnant or breastfeeding.¹,²

That applies to probiotic blends too. For the drug-level and blood sugar interactions covered here, the berberine or DHB component is the main concern, so a capsule that pairs it with probiotics carries the same questions as a standalone berberine product. The probiotic strains raise a separate safety question, especially for people who are severely ill or immunocompromised.

The medication groups below differ in how directly their interactions have been studied. A measured drug-level change deserves different weight from a laboratory signal, and DHB has less direct interaction evidence than standard berberine. Nothing here is a reason to stop or change a prescription on your own.

How strong is the evidence for each berberine interaction?

A controlled study in patients taking the actual drug is the strongest interaction evidence. Human "probe" drug studies of enzyme activity are indirect clinical evidence. Case reports show that an event happened but not how often or how large it typically is, and animal, lab, and mechanism-only data are more indirect still.

A 2026 narrative review said the quantitative interaction evidence rests mainly on three human studies: one controlled study in patients (cyclosporine in kidney transplant recipients), one probe cocktail study of goldenseal extract in healthy volunteers, and one human enzyme study.³ Small glucose and blood pressure trials, a simvastatin study, and case reports add to that, while most of the remaining data are preclinical or mechanistic.

Metformin, sulfonylureas, and insulin: does berberine stack with diabetes medication?

Berberine lowers blood sugar on its own. In a small 2008 pilot, 36 adults with newly diagnosed type 2 diabetes were randomized to berberine or metformin, each at 0.5 g three times daily for three months. The authors described the glucose-lowering effects as similar, though the trial was not designed to prove equivalence.⁴ A 2015 meta-analysis of 27 trials found berberine added to oral diabetes drugs lowered fasting and post-meal glucose and HbA1c more than the same drugs alone, though the authors rated the overall study quality as limited.⁵

Added glucose lowering matters most with the drugs that can push blood sugar too low by themselves. The National Institute of Diabetes and Digestive and Kidney Diseases names insulin and medicines that make the pancreas release more insulin, such as sulfonylureas (glipizide, glimepiride, glyburide) and meglitinides, as the diabetes drugs that can cause hypoglycemia.⁶

For sulfonylureas specifically, the interaction data come only from the lab. Memorial Sloan Kettering's About Herbs database states: "In vitro studies indicate that berberine coadministration may compromise the metabolism of sulfonylureas or mutually affect the metabolism of both compounds. Clinical relevance has yet to be determined."² The underlying study used rat liver enzymes. So the sulfonylurea concern rests on two things: berberine's own glucose effect, and an unproven lab signal.

The metformin evidence comes from goldenseal, a berberine-containing herb. In 16 healthy volunteers, a goldenseal extract standardized to berberine lowered metformin exposure by about 23%.⁷ A follow-up study in adults with type 2 diabetes found no clinically meaningful change overall, although metformin exposure dropped about 20% at low metformin doses and not at all at high doses.⁸ Because goldenseal contains other alkaloids, these findings cannot be transferred directly to berberine or DHB. Still, tell the clinician who manages your diabetes about the exact product you are considering.

Can berberine lower blood pressure too much if you take blood pressure medication?

Possibly, because both berberine and blood pressure medication can lower blood pressure. A 2022 meta-analysis of randomized trials found berberine lowered systolic blood pressure by about 5.5 mmHg on average.⁹ The 2015 meta-analysis found berberine combined with blood pressure drugs lowered pressure more than the drugs alone.⁵ That is modest for most people, but it can matter if you already run low, get dizzy on standing, or take several blood pressure drugs.

Some blood pressure drugs are also cleared by the enzymes berberine slows. In a human study, two weeks of berberine at 300 mg three times daily doubled the ratio of losartan to its active metabolite, a sign of reduced CYP2C9 activity.¹⁰ Losartan was used there as a probe, so the study did not measure blood pressure outcomes. Some beta-blockers rely on CYP2D6, which berberine also inhibited in that study.³,¹⁰

Is it safe to take berberine with a statin?

The concern is that slowing CYP3A4 could raise levels of statins cleared through it, such as simvastatin and atorvastatin.³ In the same two-week human study, berberine raised exposure to midazolam, a standard CYP3A4 probe drug, by about 40%.¹⁰ Higher statin levels can raise the risk of muscle side effects, which is why the 2026 review places statins in its "active monitoring" tier.³

The one study that tested a statin directly was more reassuring. In an open-label trial of 60 healthy Chinese adults split into five parallel groups of 12, berberine 300 mg every 8 hours for 7 days did not noticeably change simvastatin pharmacokinetics, and short-term side effects did not increase in the combination group.¹¹ With 12 people per relevant arm and a parallel design, this is limited reassurance for simvastatin at that dose.

Does berberine interact with blood thinners?

Direct human interaction evidence for berberine with warfarin remains limited. The 2026 review grades this pair as mechanism-only: warfarin is cleared partly by CYP2C9 and CYP3A4, both of which berberine inhibited in people, so a stronger anticoagulant effect is possible but unmeasured.³,¹⁰ The review still places warfarin in its high-risk tier because of warfarin's narrow therapeutic range and the consequences of excess anticoagulation, even without direct interaction data.³

If you take any anticoagulant, ask your pharmacist to check your specific drug's metabolic pathway.

Cyclosporine, tacrolimus, and other CYP3A4, CYP2D6, and P-gp drugs

This is the best-documented berberine interaction. In a randomized controlled study, 52 kidney transplant recipients took cyclosporine plus berberine 0.2 g three times daily for three months, and 52 took cyclosporine alone.¹² Cyclosporine trough levels rose in both groups, but by the end they were 29.3% higher in the berberine group than in the group without it. In a six-patient pharmacokinetic substudy, berberine raised cyclosporine exposure (AUC) by 34.5%.¹² The authors suggested this "may allow a reduction of the CsA dosage," which is a decision for a transplant team, never for a patient.

A smaller study in healthy men gave mixed results: no significant change at one cyclosporine dose and a 19.2% rise in exposure at a lower dose.¹³ For tacrolimus, MSKCC cites a case report of a child with nephrotic syndrome whose tacrolimus levels rose and who developed kidney toxicity after berberine was added.²

Beyond transplant drugs, the human enzyme study showed berberine reduced the activity of three drug-processing enzymes:¹⁰

• CYP2D6: the dextromethorphan probe ratio rose ninefold. Drugs in this pathway include some antidepressants, beta-blockers, codeine, and tramadol.³
• CYP2C9: the losartan ratio doubled.
• CYP3A4: midazolam exposure rose about 40%.

These were healthy men taking 900 mg of berberine a day, and the study measured enzyme activity rather than patient outcomes.¹⁰ MSKCC flags CYP2D6, 2C9, and 3A4 substrate drugs as a group to avoid combining with berberine.² The direction of the effect depends on the drug: slower clearance can raise levels of many active drugs, while some prodrugs that need these enzymes for activation may work less well.

Evidence for P-glycoprotein (P-gp), a pump that limits how much of some drugs gets absorbed, is weaker than for the CYP enzymes. Berberine increased digoxin absorption in animal studies, but no human study has confirmed it.³

Semaglutide or tirzepatide plus berberine: where do the effects overlap?

Direct clinical interaction evidence for berberine or DHB with semaglutide or tirzepatide remains limited.³ The concerns below come from the medicines' prescribing information and the effects reported in berberine studies, rather than from a controlled test of the combination.

Blood sugar. The Wegovy and Zepbound labels both warn that combining the drug with insulin or an insulin secretagogue, such as a sulfonylurea, may increase the risk of hypoglycemia, including severe hypoglycemia.¹⁴,¹⁵ If you also take insulin or a sulfonylurea, berberine would be one more glucose-lowering agent on top of two.

Your gut. GI side effects are the most common reactions on both drugs. In the Wegovy 2.4 mg trials, 44% of people reported nausea and 30% diarrhea, versus 16% each on placebo.¹⁴ On Zepbound 15 mg, nausea affected 28% and diarrhea 23%, versus 8% each on placebo.¹⁵ Berberine's own reported side effects are mostly digestive: nausea, abdominal pain, bloating, constipation, or diarrhea.¹ In the 2008 diabetes pilot, 34.5% of people taking berberine had transient GI effects, mostly in the first four weeks.⁴

When both can upset your stomach, it gets harder to tell which one is causing a problem, particularly while a GLP-1 dose is being increased. For a broader look at combining our probiotics with GLP-1 drugs, see Can I take WonderBiotics with semaglutide or tirzepatide?

Why berberine and DHB are not recommended during pregnancy or breastfeeding

The National Center for Complementary and Integrative Health states that berberine exposure "has been linked to a harmful buildup of bilirubin in infants, which can cause brain damage," and that berberine "may also be unsafe for use during pregnancy or while breastfeeding."¹ MSKCC advises that berberine "should be avoided by those who are pregnant or breastfeeding" because it may worsen infant jaundice or lead to kernicterus.²

The mechanism comes from lab and animal work. In a 1993 study, berberine displaced bilirubin from albumin about ten times more strongly than phenylbutazone, a known displacer, and raised bilirubin levels in rats.¹⁶ That paper was prompted by reports of kernicterus risk in jaundiced newborns given a berberine-rich herb.¹⁶ No controlled studies in pregnant or breastfeeding women exist to show the risk is low, and DHB has no separate safety data in pregnancy. The consistent advice from both NCCIH and MSKCC is to avoid it.

What do we know about dihydroberberine interactions specifically?

DHB-specific human evidence is very limited. DHB is a reduced form of berberine designed for better absorption. In a five-person crossover pilot in healthy men, each study period used four doses over two days. At 100 mg per dose, DHB produced greater two-hour plasma berberine exposure than standard berberine at 500 mg per dose.¹⁷ That study was funded by a DHB ingredient supplier, and one author was a paid consultant to that company.¹⁷

No study has shown that DHB shares every berberine interaction. Because it can raise plasma berberine exposure, applying berberine's precautions to DHB is the conservative approach. Dedicated human drug-interaction data for DHB remain limited, so its absorption profile cannot establish combination safety. A 2026 review of DHB found that human trials remain limited and flagged potential hERG channel inhibition, a preclinical signal linked to heart rhythm, as a risk that "required careful evaluation."¹⁸

One 2026 case report describes a 61-year-old man with a dangerous heart rhythm (torsades de pointes, QTc 669 ms) who was taking berberine, DHB, turmeric, and quercetin and had mildly low magnesium.¹⁹ The authors described a "multihit" picture, so no single supplement can be blamed. If you take any drug known to affect heart rhythm, or have a history of long QT, put this on your list for your doctor.

Where probiotic-plus-DHB combinations fit

Our WonderBiotics Probiotics for Weight Management contains dihydroberberine alongside its probiotic strains and eriocitrin-standardized lemon extract. If you take any of the medications in this article, check with your doctor before starting it. You can review the full formula on the WonderBiotics Probiotics for Weight Management page and bring the label to that conversation.

Cyclosporine and tacrolimus also raise a probiotic-specific consideration. These drugs suppress the immune system, and NCCIH notes that the risk of harmful effects from probiotics is greater in people with compromised immune systems.²⁰

Questions to ask your doctor or pharmacist before starting berberine or DHB

Bring the supplement bottle, or a photo of its Supplement Facts panel, plus your full medication list. Then ask:

1. Do any of my medications rely on CYP3A4, CYP2D6, CYP2C9, or P-glycoprotein?
2. I take [insulin / a sulfonylurea / a meglitinide / metformin]. Is my risk of low blood sugar high enough that a glucose-lowering supplement is a bad idea right now?
3. If you are open to it, should I check my blood sugar more often for the first few weeks, and what reading should make me call?
4. My blood pressure medication is [name]. Should I track home readings after starting, and what numbers or symptoms matter?
5. I take [statin name]. Which muscle symptoms should I report?
6. I take [anticoagulant name]. Does this supplement change how often my levels or INR should be checked?
7. I take cyclosporine, tacrolimus, or another drug with a narrow therapeutic range. Should I avoid this product entirely?
8. I am on semaglutide or tirzepatide. Should I wait until my dose is stable before adding anything new?
9. Do any of my medications affect heart rhythm, and does that change your answer?
10. I am pregnant, planning pregnancy, or breastfeeding. Is there any reason this would be appropriate for me?

Any answer applies to the exact product, dose, and medication list you discussed, so bring the question back if any of those change.

When a symptom needs attention right away

Do not stop, skip, or adjust a prescription because of anything you read here. If you have already started a berberine or DHB supplement and notice signs of low blood sugar, such as shakiness, hunger, dizziness, confusion, or a fast heartbeat, follow the plan your care team gave you and contact them.⁶ Severe low blood sugar, such as passing out or having a seizure, needs emergency care.⁶ So does fainting or a racing, irregular heartbeat.

Berberine and DHB are supplement ingredients, not treatments for diabetes, high blood pressure, or high cholesterol, and neither replaces prescribed therapy. Talk through the specific product, dose, and your medication list with your clinician before you start.

References

1. National Center for Complementary and Integrative Health. Berberine and Weight Loss: What You Need To Know.
2. Memorial Sloan Kettering Cancer Center. About Herbs: Berberine.
3. Dumitru CN, Marcu T, Dumitru AO, et al. Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification. A Narrative Review. Pharmaceuticals (Basel). 2026;19(8):1313. PMID 42653808.
4. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. PMID 18442638.
5. Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015;161:69-81. PMID 25498346.
6. National Institute of Diabetes and Digestive and Kidney Diseases. Low Blood Glucose (Hypoglycemia).
7. Nguyen JT, Tian DD, Tanna RS, et al. Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail. Clin Pharmacol Ther. 2021;109(5):1342-1352. PMID 33174626.
8. Nguyen JT, Arian CM, Tanna RS, et al. The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent. Clin Transl Sci. 2025;18(2):e70120. PMID 39943692.
9. Zamani M, Zarei M, Nikbaf-Shandiz M, et al. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis. Front Nutr. 2022;9:1013055. PMID 36313096.
10. Guo Y, Chen Y, Tan ZR, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-217. PMID 21870106.
11. Li G, Zhao M, Qiu F, et al. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate. Drug Des Devel Ther. 2019;13:129-139. PMID 30587933.
12. Wu X, Li Q, Xin H, et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol. 2005;61(8):567-572. PMID 16133554.
13. Xin HW, Wu XC, Li Q, et al. The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers. Methods Find Exp Clin Pharmacol. 2006;28(1):25-29. PMID 16541194.
14. Novo Nordisk. Wegovy (semaglutide) injection Prescribing Information. DailyMed.
15. Eli Lilly and Company. Zepbound (tirzepatide) injection Prescribing Information. DailyMed.
16. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate. 1993;63(4):201-208. PMID 8513024.
17. Moon JM, Ratliff KM, Hagele AM, et al. Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial. Nutrients. 2022;14(1):124. PMID 35010998.
18. Wang D, Tang Y. Dihydroberberine in metabolic disorders: Bioavailability, molecular mechanisms, toxicology, and future perspectives. Food Chem Toxicol. 2026;216:116267. PMID 42398618.
19. Mohammadi A, Abdalla HM, Falls N, et al. Recurrent Torsades de Pointes Precipitated by Berberine Supplement. JACC Case Rep. 2026. PMID 42684237.
20. National Center for Complementary and Integrative Health. Probiotics: Usefulness and Safety.